 |
SP fertility drug meets study goalsSchering-Plough Corporation, a worldwide research-based pharmaceutical company, on Tuesday said its experimental treatment for infertility, a follicle stimulant called corifollitropin alfa, met its main goals in a late-stage study. The dat More… |
Thursday 9 May 2024
